Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Public ClinicalTrials.gov record NCT02461602. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Eliminate Thromboembolism (ELITE): Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
ELITE (Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients) is a two year research project to assess warfarin management issues faced by atrial fibrillation (AF) patients in ambulatory settings.
Study identification
- NCT ID
- NCT02461602
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 251 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2016 (Actual)
- Primary completion
- May 31, 2018 (Actual)
- Completion
- May 31, 2018 (Actual)
- Last update posted
- Apr 9, 2019
2016 – 2018
United States locations
- U.S. sites
- 21
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Foothill Cardiology | Pasadena | California | 91105 | — |
| Holy Cross Medical Group | Coral Springs | Florida | 33065 | — |
| Charlotte Heart Group | Port Charlotte | Florida | 33952 | — |
| Atlanta Institute for Medical Research, Inc. | Atlanta | Georgia | 30350 | — |
| Atlanta Heart Specialists | Cumming | Georgia | 30041 | — |
| Cardiovascular Research of Northwest Indiana, L.L.C. | Munster | Indiana | 46321 | — |
| Research Integrity, LLC. | Owensboro | Kentucky | 42303 | — |
| Ochsner Health System | New Orleans | Louisiana | 70121 | — |
| Penobscot Bay Medical Center | Rockport | Maine | 04856 | — |
| Endeavor Medical Research | Alpena | Michigan | 49707 | — |
| Great Lakes Heart and Vascular Institute | Saint Joseph | Michigan | 49085 | — |
| HealthEast Medical Research Institute | Saint Paul | Minnesota | 55102 | — |
| Jackson Heart Clinic | Jackson | Mississippi | 39216 | — |
| Cardiovascular Associates of the Delaware Valley | Elmer | New Jersey | 08318 | — |
| Lourdes Cardiology Services | Voorhees Township | New Jersey | 08043 | — |
| Duke Cardiology of Lumberton | Lumberton | North Carolina | 28358 | — |
| Doylestown Health Cardiology | Doylestown | Pennsylvania | 18901 | — |
| Columbia Heart Clinic, PA | Columbia | South Carolina | 29203 | — |
| North Texas Research Associates | Allen | Texas | 75013 | — |
| Providence Health Center | Waco | Texas | 76712 | — |
| Riverside Cardiology Specialists | Newport News | Virginia | 23601 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02461602, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02461602 live on ClinicalTrials.gov.